Clinical Trials in Austin

Showing 7901-7920 of 15,205 trials

Phase 3 Study Evaluating Safety and Efficacy of OTX-TP in Subjects With OAG or OHT

NCT02914509

The objective of the study is to evaluate evaluate the safety and IOP lowering efficacy of OTX-TP, a sustained release travoprost drug product, placed in the canaliculus of the eyelid in the treatment of subjects with open-angle glaucoma or ocular hypertension

Open Angle GlaucomaOcular Hypertension

Ocular Therapeutix, Inc.565 participantsStarted Nov 2016

Artesia, California, United States • Colorado Springs, Colorado, United States • Lakeland, Florida, United States +7 more locations

COMPLETEDPhase 2< 1 mile

A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder

NCT02161718

This double-blind, randomized study will evaluate the efficacy, safety and tolerability of ALKS 3831 in subjects with schizophrenia and alcohol use disorder (AUD).

SchizophreniaAlcohol Use Disorder

Alkermes, Inc.300 participantsStarted May 2014

Little Rock, Arkansas, United States • Springdale, Arkansas, United States • Anaheim, California, United States +68 more locations

Phase 3 Study Evaluating Safety and Efficacy of OTX-TP in Subjects With OAG or OHT

A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder

Find Trials by Condition in Austin

A 12 Week Randomized Open Label Parallel Group Multicenter Study to Evaluate Bioequivalence of 20 mg Subcutaneous Ofatumumab Injected by Pre-filled Syringe or Autoinjector in Adult RMS Patients

Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine

The (PIVOTAL) Study

Post-market Study to Obtain Surgeon Feedback on Clinical Outcome in Eyes Implanted With TECNIS Toric II IOL

Study of Efficacy and Safety of Secukinumab 2 mL Auto-injector (300 mg) in Subjects With Moderate to Severe Plaque Psoriasis

A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod

Efficacy and Safety Study of Benralizumab for Patients With Severe Nasal Polyposis

A Safety Extension Study to Evaluate the Long-term Safety of QGE031 in Chronic Spontaneous Urticaria (CSU) Patients

Comparison Between iLux and LipiFlow in the Treatment of Meibomian Gland Dysfunction (MGD): A 12-month, Multicenter Study

Hydroxychloroquine Monotherapy and in Combination With Azithromycin in Patients With Moderate and Severe COVID-19 Disease

Long-Term Extension of Previous rAvPAL-PEG Protocols in Subjects With PKU (PAL-003)

Safety, Efficacy and Pharmacokinetics of CF-301 vs. Placebo in Addition to Antibacterial Therapy for Treatment of S. Aureus Bacteremia

Proof of Concept Study Evaluating the Efficacy and Safety of MIJ821 in Patients With Treatment-resistant Depression

Study of Efficacy and Safety of LOU064 in Inadequately Controlled Asthma Patients

Study to Assess the Efficacy and Safety of CJM112 in Patients With Inadequately Controlled Severe Asthma

Study to Compare QVM149 and Free Triple Combination of Salmeterol/Fluticasone + Tiotropium

A Study of MM-121 in Combination With Chemotherapy Versus Chemotherapy Alone in Heregulin Positive NSCLC

Study of Efficacy of Fevipiprant in Patients With Nasal Polyposis and Asthma